Mr. George W. BickerstaffBoard Member Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • Pennsylvania
On behalf of Viventia Bio Inc., a Canadian corporation (the “Company”). I am very pleased you have agreed to join our board of directors (the “Board”). This agreement lays out the terms and conditions in connection with your service. Should you have any questions or concerns please do not hesitate to let me know.
EMPLOYMENT AGREEMENTEmployment Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • New Jersey
EMPLOYMENT AGREEMENT (the “Agreement”) dated as of August 10, 2015, between Viventia Bio USA Inc., a corporation incorporated under the laws of Mannitoba, Canada (the “Company”), and Arthur P. DeCillis, M.D., currently a resident of 80 Devonshire Lane Madison, CT 06443 (the “Employee”).
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances)
This AMENDED AND RESTATED LICENSE AGREEMENT is made and entered into by and between Protoden Technologies Inc. and Viventia Bio Inc. as of the Effective Date (as defined below).
Dr. Martin Barkin Re: Viventia Bio Inc. Dear Martin:Board Member Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • Pennsylvania
On behalf of Viventia Bio Inc., a Canadian corporation (the “Company”). I am very pleased you have agreed to join our board of directors (the “Board”). This agreement lays out the terms and conditions in connection with your service. Should you have any questions or concerns please do not hesitate to let me know.
EMPLOYMENT AGREEMENTEmployment Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • Ontario
NOW THEREFORE in consideration of the mutual covenants and agreements contained in this Agreement and other good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged), the Corporation and the Executive agree as follows:
Amendment to Loan AgreementLoan Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • Ontario
WHEREAS the Borrower is a wholly owned subsidiary of the Lender, and has borrowed funds from the Lender pursuant to that certain loan agreement made as of the 23rd day September, 2014 (the “Loan Agreement”);
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • New Jersey
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) dated as of December 11, 2014, between Viventia Bio USA Inc., a corporation incorporated under the laws of the Province of Ontario, Canada (the “Company”), and Stephen Hurly, currently a resident of Haddonfield in the State of New Jersey, (the “Employee”).
Loan AgreementLoan Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • Ontario
WHEREAS the Borrower is an indirect subsidiary of the Lender and has entered into this Loan Agreement to induce the Lender to make a Loan Facility available to the Borrower on the terms and conditions set out herein;
ContractAsset Purchase Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • Ontario
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
ContractLicense Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances)
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE VIVENTIA BIO INC. EQUITY INCENTIVE PLANRestricted Stock Unit Award Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances)
THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”) is made by and between Viventia Bio Inc. (the “Company”) and Stephen Hurly (the “Participant”) as of this 11th day of December 2014 (the “Effective Date”)
AMENDED & RESTATED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • New York
This Exclusive License Agreement (this “Agreement”) is effective as of the 8th day of March, 2004,(the “Effective Date”) and amended and restated as of October 14, 2015 to reflect Amendment 1 and 2 between Merck KGaA, of Frankfurter Str. 250, 64293 Darmstadt, Germany (hereinafter called “Merck,” which expression includes its successors and assigns) of the one part and Viventia Bio, Inc., of 147 Hamelin Street, Winnipeg MB, R3T 3Z1, CANADA (hereinafter called “Viventia,” which expression includes its successors and permitted assignees) of the other part. Each of Merck and Viventia are herein sometimes referred to individually as a “Party” and collectively as “Parties.”
OPTION AWARD AGREEMENT UNDER THE VIVENTIA BIO INC. EQUITY INCENTIVE PLANOption Award Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances)
THIS OPTION AWARD AGREEMENT (this “Agreement”) is made by and between Viventia Bio Inc. (the “Company”) and (the “Participant”) as of this day of (the “Effective Date”).
RESTRICTED STOCK AGREEMENT UNDER THE VIVENTIA BIO INC. EQUITY INCENTIVE PLANRestricted Stock Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances)
THIS RESTRICTED STOCK AGREEMENT (this “Agreement”) is made by and between Viventia Bio Inc. (the “Company”) and (the “Participant”) as of this th day of (the “Effective Date”).
THIS INDENTURE made as of the 31st day of March, 2000 BETWEEN:Lease Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • Manitoba
WITNESSETH that in consideration of the rents, covenants and agreements hereinafter reserved and contained on the part of the Tenant to be paid, observed and performed, the Landlord has demised and leased, and by these presents does demise and lease unto the Tenant approximately Twenty One Thousand Five Hundred (21,500) square feet of Rentable Area (the “Leased Premises”) commonly known as 136-147 Hamelin Street, in the City of Winnipeg, in the Province of Manitoba forming part of the property (the “Property”), commonly known as 131-147 Hamelin Street in the City of Winnipeg, in the Province of Manitoba;
Partial Loan Conversion AgreementPartial Loan Conversion Agreement • October 21st, 2015 • Viventia Bio Inc. • Biological products, (no disgnostic substances) • Ontario
WHEREAS the Borrower is a majority owned subsidiary of the Lender, and has borrowed funds from the Lender pursuant to that certain loan agreement made as of the 23rd day September, 2014 and as amended on the 16th day of September, 2015 (the “Loan Agreement”);
